The transition of a synthetic peptide from research to commercialization requires robust analytical method development and validation, particularly the establishment of highly specific, stability-indi...
Read more
Taking advantage of advancements in business intelligence, clinical research has transitioned from manual data processing to sophisticated AI-driven analytics, bridging the gap between clinical and bu...
Read more
CROs that offer patient payment and reimbursement services play a strategic role in ensuring that everything is carried out with maximum transparency.
Read more
What happens when a clinical trial fails to comply with regulations? Fines, delays, and loss of credibility are just the tip of the iceberg. In a sector where patient safety and scientific integrity a...
Read more
In today’s rapidly evolving biopharmaceutical landscape, selecting the right Contract Development and Manufacturing Organization (CDMO) is one of the most strategic decisions a company can make. Whe...
Read more
Process validation ensures manufacturing consistency, reduces deviations, prevents rework, improves resource utilization, and facilitates production scale-up. As a direct result, it accelerates time t...
Read more
Drug-resistant epilepsy (DRE) is one of the most significant challenges in modern neurology. Affecting approximately 15-16 million people worldwide—about 30% of all individuals with epilepsy¹—thi...
Read more
3PBIOVIAN strengthens its international R&D positioning with French CIR certification at its sites in Spain and Finland
Read more
Reaching the point where GMP manufacturing becomes a real requirement is a defining milestone for any biologics program. At this stage, development decisions are no longer theoretical. They directly a...
Read more
Outsourcing analytical development, more than a cost-saving mechanism, has become a strategic lever that shapes data quality, regulatory confidence, and development speed. When aligned correctly, anal...
Read more
GMP manufacturing pitfalls that delay biologics production can increase costs, disrupt clinical timelines, and compromise regulatory readiness if not addressed early.
Read more
Agarose Bead Technologies will be attending Bioprocessing Summit Europe 2026 in Barcelona, March 10–12. That means another opportunity to reconnect with partners, meet new industry professionals, an...
Read more
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Telum Therapeutics, a biotechnology company leveraging proprietary met...
